Introduction
One in five of all ischemic strokes (IS) can be attributed to atrial Fibrillation (AF) 1 .
The risk of recurrence is 22% in cases of cardio embolic stroke 2 and oral anticoagulation would be needed for patients with AF. Documentation of AF by electrocardiogram is generally required to initiate oral anticoagulation for secondary prevention after IS, but in the absence of documented AF, antiplatelet agents are usually recommended 3 . A simple way to 'flag up' patients with a high risk of developing incident AF after IS for more intense monitoring strategies or follow-up would help management. The CHA 2 DS 2 -VASc score has been widely used to estimate the risk of stroke in patients with AF 4 and for adverse outcomes even in patients without known AF 5, 6 . Its usefulness for prediction of new AF in patients after IS has also been observed in a French Nationwide Cohort Study 7 . AF has been associated with a stronger relative risk of IS in women than in men 8, 9 . Importantly, mechanisms and comorbidities associated with AF incidence may differ between men and women 10 . We aimed to compare gender-related differences in items from CHA 2 DS 2 -VASc score and their relationship with differences in AF occurrence between men and women after IS. inpatients in the 1,546 French healthcare facilities. The reliability of PMSI data has already been assessed 11 and has previously been used to study patients with stroke and AF 7, 12, 13 .
METHODS

This
This study was approved by the institutional review board of the Pole Coeur Thorax
Vaisseaux from the Trousseau University Hospital, on December 1, 2015 and registered as a clinical audit. Ethical review was therefore not required. Patient consent was not sought. The study was conducted retrospectively, patients were not involved in its conduct, and there was no impact on their care. Procedures for data collection and management were approved by the Conseil National de l'Informatique et des Libertés, the independent National ethical committee protecting human rights in France which ensures that all information is kept confidential and anonymous (authorization number 1749007).
The study included adults (≥18 years) with a diagnosis of acute IS (I63 and its subsections using ICD10 codes) coded in the principal diagnosis (i.e. the health problem that justified admission to hospital), the related diagnosis (i.e. potential chronic disease or health state during hospital stay) or the significantly associated diagnosis (i.e. comorbidity or associated complication) who were hospitalized from January 1, 2008 to December 31, 2012.
We made an analysis restricted to the patients seen after 2009, meaning that all patients had at least 1 year where previous events were recorded to establish history of previous AF and comorbidities. Patients with no diagnosis of AF were considered as having sinus rhythm. Of note, asymptomatic cerebrovascular diseases and sequelae of stroke have different codes (I65-I66 and I69 with subdivisions) to be distinguished from acute strokes in the patients of our analysis. Patient information (demographics, comorbid conditions, medical history, and events during follow-up or during hospitalization) was described using data collected in the hospital records. For each hospital stay, all diagnoses were obtained together at discharge. We calculated the CHA 2 DS 2 -VASc score as previously described 4 .
Qualitative variables are described using counts and percentages, and continuous Of these patients, a total of 14,095 (5.9%) without AF at baseline, were diagnosed as having incident AF during a subsequent hospitalization over a mean follow-up of 7.9±11.5 months ( Table 2 ). The total yearly incidence rate for AF for participants with IS was 8.9 per 100 person-years (95% confidence interval [CI] 8.8-9.0-7.9). Patients with AF during followup were significantly older, including a higher proportion of women, and more prevalent items of the CHA 2 DS 2 -VASc score than patient without AF during follow-up.
Predictors of incident AF are shown in Table 3 for the whole population, and in Table   4 for men and for women. In the whole population, most powerful predictors of incident AF (hazard ratio [HR] ≥1.20) were older age, hypertension, heart failure (among items of the CHA 2 DS 2 -VASc score), coronary artery disease, valvular disease and history of pacemaker/defibrillator implantation. The association between vascular disease and AF occurrence was weaker and borderline to significance for female gender after adjusting for other items. Diabetes mellitus was associated with a higher incidence of AF in univariate analysis but was independently associated with a lower rate of incident AF on multivariable analysis. Results were broadly similar when one analysed separately men and women, except for obesity, abnormal renal function and anaemia (predictor of incident AF in men whilst not significant predictors of AF in women). 
DISCUSSION
Our results confirm that IS was associated with substantially increased risk of AF among individuals with higher CHA 2 DS 2 -VASc score, as previously reported 16 . However, we extend prior observations by showing significant differences in comorbidities and incidence of AF in men and women after IS. Furthermore, CHA 2 DS 2 -VASc had a slightly better ability to predict incident AF diagnosed in men than in women after IS. Thus, this score would be a simple way to 'flag up' high risk patients for more intense monitoring strategies or follow-up (even in primary care) would help the holistic management of such patients.
Women and men may have different sequelae to various risk factors for cardiovascular disease 9, 14 . Previous analyses have shown that smoking and diabetes are associated with greater proportional risks of coronary heart disease in women than in men 15, 16 . It is currently unclear, however, whether such sex differences exist for incident AF, whilst conversely AF is a stronger risk factor for cardiovascular disease and death in women compared with men 9,17 .
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The CHA 2 DS 2 -VASc score is a validated tool to estimate the risk of stroke in patients with documented AF. The pre-stroke CHA 2 DS 2 -VASc score has also been associated with neurological outcomes following IS in patients with AF 18, 19 . It has also been linked to longterm mortality, stroke recurrence and cardiovascular events in IS patients without AF 20 . The CHA 2 DS 2 -VASc score has also been useful in predicting the risk of incident AF in a large population 21 and in patients after IS 7 . Whether this simple score works similarly in men and women has not been previously established.
We found marked differences in baseline characteristics of men and women experiencing IS, whereby women were older and had more hypertension, heart failure and accordingly a higher CHA 2 DS 2 -VASc score. By contrast, they less frequently had coronary or vascular disease, lung disease or renal failure, which may be due to their lower prevalence of dyslipidaemia and tobacco smoking at baseline. The incidence of new incident AF was high, and this rises the possibility that IS was cardioembolic in a vast part of this population, although we were not able to identify the subtypes of IS. The annual incidence of AF after IS was greater in women than in men. The older age, more frequent comorbidities and higher CHA 2 DS 2 -VASc score at baseline in women may explain these results. An easier and earlier diagnosis of AF might be possible in women because asymptomatic AF is less common in females 22 , which may be related to their older age and more frequent comorbidities.
There are few tools integrating multiple risk factors to establish an individual's absolute risk of incident AF post-stroke while risk factors such as ageing, diabetes mellitus, hypertension, obesity, and cardiovascular disease, including alterations in cardiac structure and function consistently predispose individuals to AF [23] [24] [25] . Many components of the CHA 2 DS 2 -VASc scores are associated with higher prevalence of AF. Consistently reported risk indicators of incident AF in the general population or after IS were sex, older age, body mass index, hypertension, heart failure, myocardial infarction and valvular heart disease 7,23,25 .
We found that diabetes mellitus was independently associated with a lower risk of AF after IS. Previous epidemiological studies have reported on the association between diabetes mellitus and subsequent risk of AF, with inconsistent results 26 . Diabetes seems less strongly associated with AF than with other cardiovascular diseases and the causality link between diabetes and AF has been debated because of the frequent association with hypertension and obesity. In several cohort analyses, diabetes was less frequent in patients with cardioembolic stroke than in patients with other causes of IS 2, 27, 28 . Patients with diabetes could also be exposed to more silent AF and our study did not evaluate this issue.
Similarly, vascular disease (as defined in the CHA 2 DS 2 -VASc score) was associated with a lower AF incidence in women. We may hypothesize that vascular disease is more likely to be associated with large artery or small vessel pathology in women with IS (and less likely to be associated with IS of thromboembolic origin), which may explain the lower association with incident AF occurrence in spite of females being older than males at baseline.
This might also explain why the CHA 2 DS 2 -VASc score had a lower predictive ability to identify the risk of incident AF in women compared to men in our analysis. However, coronary artery disease per se was associated with a higher incidence of AF in both genders.
In spite of these differences, the CHA 2 DS 2 -VASc score was able to predict subsequent AF in those patients with IS in both genders similarly, although the diagnostic value of the CHA 2 DS 2 -VASc score was slightly higher in men. Higher scores identified patients more likely to develop incident AF, and our findings help targeting patients at highest risk of AF in both groups of male and female patients. Some other characteristics not included in the A limitation of this study is inherent to its retrospective observational nature. Even though the reliability of PMSI data has been verified previously 11 and used for epidemiological purposes in AF 7, 13 , the analysis presents inherent potential information bias.
The study methodology possibly underestimated the true incidence of AF in this population and may overestimate the importance of the components of the CHA 2 DS 2 -VASc score and comorbidities, which might predispose to hospitalization. Besides, some echocardiographic parameters may help to identify risk of AF 27 , and these parameters were lacking in the present study. However, the goal of the present study was to use a simple clinical risk score for predicting the risk of new-onset AF in patients without performing further examinations.
Considering its often paroxysmal and asymptomatic nature, AF may not be detected very early with the use of traditional monitoring techniques 29, 30 . The analysis also presents inherent potential for information bias, given that no information was available for medications, drug misuse, and international normalized ratios.
In conclusion, among IS patients without known AF, the CHA 2 DS 2 -VASc score is simple risk tool for identifying patients at higher risk of developing incident AF following IS.
Whilst there were significant differences in comorbidities, possible mechanisms and incidence of AF between men and women after IS, a strategy using CHA 2 DS 2 -VASc score for identifying a higher risk of incident AF was similarly useful in both genders. 
